Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Cancer epigenetics: Moving for...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Cancer epigenetics: Moving forward.

Cancer epigenetics: Moving forward.

Defects in chromatin modifiers and remodelers have been described both for hematological and solid malignancies, corroborating and strengthening the role of epigenetic aberrations in the etiology of cancer. Furthermore, epigenetic marks-DNA methylation, histone modifications, chromatin remodeling, a...

Full description

Bibliographic Details
Main Authors: Angela Nebbioso, Francesco Paolo Tambaro, Carmela Dell'Aversana, Lucia Altucci
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-06-01
Series:PLoS Genetics
Online Access:https://storage.googleapis.com/plos-corpus-prod/10.1371/journal.pgen.1007362/1/pgen.1007362.pdf?X-Goog-Algorithm=GOOG4-RSA-SHA256&X-Goog-Credential=wombat-sa%40plos-prod.iam.gserviceaccount.com%2F20210222%2Fauto%2Fstorage%2Fgoog4_request&X-Goog-Date=20210222T021120Z&X-Goog-Expires=3600&X-Goog-SignedHeaders=host&X-Goog-Signature=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
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://storage.googleapis.com/plos-corpus-prod/10.1371/journal.pgen.1007362/1/pgen.1007362.pdf?X-Goog-Algorithm=GOOG4-RSA-SHA256&X-Goog-Credential=wombat-sa%40plos-prod.iam.gserviceaccount.com%2F20210222%2Fauto%2Fstorage%2Fgoog4_request&X-Goog-Date=20210222T021120Z&X-Goog-Expires=3600&X-Goog-SignedHeaders=host&X-Goog-Signature=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

Similar Items

  • Single-Cell Photothermal Analysis Induced by MoS2 Nanoparticles by Raman Spectroscopy
    by: Giulia Rusciano, et al.
    Published: (2022-03-01)
  • Breast Cancer Vaccines: New Insights
    by: Rosaria Benedetti, et al.
    Published: (2017-10-01)
  • Extracellular Vesicle-Based Nucleic Acid Delivery: Current Advances and Future Perspectives in Cancer Therapeutic Strategies
    by: Crescenzo Massaro, et al.
    Published: (2020-10-01)
  • HIF3A Inhibition Triggers Browning of White Adipocytes via Metabolic Rewiring
    by: Francesca Cuomo, et al.
    Published: (2022-01-01)
  • MicroRNA-Assisted Hormone Cell Signaling in Colorectal Cancer Resistance
    by: Crescenzo Massaro, et al.
    Published: (2020-12-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs